According to seven different market research organizations, the “Agentic AI in clinical trials market” is expected to grow at a compound annual growth rate (CAGR) of anywhere between 12.5% to 43%. While the estimates obviously vary depending on who you ask, one thing remains crystal clear, agentic AI in clinical trials isn’t slowing down. As sponsors and CROs increasingly implement artificial intelligence, many organizations approaching clinical AI face real anxiety about the clinical trustworthiness of AI.